Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Zhang

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
International Journal of Environmental Research and Public Health|July 29, 2020
Manipulation of Lateral Pharyngeal Wall Muscles in Sleep Surgery: A Review of the LiteratureGiovanni Cammaroto, Luigi Marco Stringa, Giannicola Iannella, et al.
International Journal of Environmental Research and Public Health|March 25, 2020
Acquired Nasopharyngeal Stenosis Correction Using a Modified Palatal Flaps Technique in Obstructive Sleep Apnea (OSA) PatientsGiovanni Cammaroto, Luigi Marco Stringa, Luca Cerritelli, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 3: 5-Substituted 3-phenyl-1,2,4-oxadiazoles as potent antagonistsGregory A Gfesser, Henry Zhang, Jurgen Dinges, et al.
JAMA Cardiology|August 20, 2025
Artificial Intelligence-Enhanced Electrocardiography for Complete Heart Block Risk StratificationArunashis Sau, Henry Zhang, Joseph Barker, et al.
Frontiers in Molecular Neuroscience|December 13, 2021
Treating Metastatic Brain Cancers With Stem CellsNadia Sadanandan, Alex Shear, Beverly Brooks, et al.
Cell Death Discovery|September 24, 2022
Inflammatory gut as a pathologic and therapeutic target in Parkinson's diseaseJea-Young Lee, Zhen-Jie Wang, Alexa Moscatello, et al.
Journal of Medicinal Chemistry|May 28, 2004
Synthesis and structure-activity relationships of a novel series of tricyclic dihydropyridine-based KATP openers that potently inhibit bladder contractions in vitroWilliam A Carroll, Konstantinos A Agrios, Robert J Altenbach, et al.
Neuroscience and Biobehavioral Reviews|December 28, 2020
Progress in progestin-based therapies for neurological disordersRegine Sitruk-Ware, Brooke Bonsack, Roberta Brinton, et al.
The Lancet. Digital Health|October 25, 2024
Artificial intelligence-enabled electrocardiogram for mortality and cardiovascular risk estimation: a model development and validation studyArunashis Sau, Libor Pastika, Ewa Sieliwonczyk, et al.
Journal of Medicinal Chemistry|May 28, 2004
Synthesis and structure-activity relationships of a novel series of 2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide K(ATP) channel openers: discovery of (-)-(9S)-9-(3-bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a potent K(ATP) opener that selectively inhibits spontaneous bladder contractionsWilliam A Carroll, Robert J Altenbach, Hao Bai, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
International Journal of Environmental Research and Public Health|July 29, 2020
Manipulation of Lateral Pharyngeal Wall Muscles in Sleep Surgery: A Review of the LiteratureGiovanni Cammaroto, Luigi Marco Stringa, Giannicola Iannella, et al.
International Journal of Environmental Research and Public Health|March 25, 2020
Acquired Nasopharyngeal Stenosis Correction Using a Modified Palatal Flaps Technique in Obstructive Sleep Apnea (OSA) PatientsGiovanni Cammaroto, Luigi Marco Stringa, Luca Cerritelli, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 3: 5-Substituted 3-phenyl-1,2,4-oxadiazoles as potent antagonistsGregory A Gfesser, Henry Zhang, Jurgen Dinges, et al.
JAMA Cardiology|August 20, 2025
Artificial Intelligence-Enhanced Electrocardiography for Complete Heart Block Risk StratificationArunashis Sau, Henry Zhang, Joseph Barker, et al.
Frontiers in Molecular Neuroscience|December 13, 2021
Treating Metastatic Brain Cancers With Stem CellsNadia Sadanandan, Alex Shear, Beverly Brooks, et al.
Cell Death Discovery|September 24, 2022
Inflammatory gut as a pathologic and therapeutic target in Parkinson's diseaseJea-Young Lee, Zhen-Jie Wang, Alexa Moscatello, et al.
Journal of Medicinal Chemistry|May 28, 2004
Synthesis and structure-activity relationships of a novel series of tricyclic dihydropyridine-based KATP openers that potently inhibit bladder contractions in vitroWilliam A Carroll, Konstantinos A Agrios, Robert J Altenbach, et al.
Neuroscience and Biobehavioral Reviews|December 28, 2020
Progress in progestin-based therapies for neurological disordersRegine Sitruk-Ware, Brooke Bonsack, Roberta Brinton, et al.
The Lancet. Digital Health|October 25, 2024
Artificial intelligence-enabled electrocardiogram for mortality and cardiovascular risk estimation: a model development and validation studyArunashis Sau, Libor Pastika, Ewa Sieliwonczyk, et al.
Journal of Medicinal Chemistry|May 28, 2004
Synthesis and structure-activity relationships of a novel series of 2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide K(ATP) channel openers: discovery of (-)-(9S)-9-(3-bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a potent K(ATP) opener that selectively inhibits spontaneous bladder contractionsWilliam A Carroll, Robert J Altenbach, Hao Bai, et al.
Pageof 6